Scarica l'app Stockscreener
7.56
2.70%
-0.21
Lifecore Biomedical Inc Borsa (LFCR) Ultime notizie
Important Notice to Long-Term Shareholders of Integer - GlobeNewswire
Aug Selloffs: Why Lifecore Biomedical Inc. stock attracts high net worth investors2025 Market Sentiment & Stock Market Timing Techniques - ulpravda.ru
Why Lifecore Biomedical Inc. stock attracts high net worth investorsDividend Hike & Low Volatility Stock Recommendations - ulpravda.ru
Is Lifecore Biomedical Inc. stock dividend yield sustainableWeekly Market Report & Daily Stock Trend Watchlist - ulpravda.ru
Why Lifecore Biomedical Inc. stock could rally in 2025July 2025 Volume & Risk Adjusted Buy and Sell Alerts - ulpravda.ru
How institutional buying supports Lifecore Biomedical Inc. stock2025 Support & Resistance & Real-Time Chart Breakout Alerts - ulpravda.ru
Notice to Long-Term Shareholders of Lifecore Biomedical, Inc. (LFCR): Grabar Law Office Investigates Claims on Your Behalf as Securities Fraud Class Action Reaches Settlement - TMX Newsfile
Why Lifecore Biomedical Inc. stock is a must watch in 2025Market Activity Recap & Weekly Setup with ROI Potential - ulpravda.ru
Activity Recap: Why Lifecore Biomedical Inc. stock is a must watch in 2025Trade Exit Report & Reliable Breakout Forecasts - ulpravda.ru
Will Lifecore Biomedical Inc. stock gain from lower inflationJuly 2025 Opening Moves & Long Hold Capital Preservation Tips - ulpravda.ru
Published on: 2026-01-07 20:37:50 - ulpravda.ru
MSN Money - MSN
Notice to Long-Term Shareholders of Cytokinetics, Inc. (NASDAQ: CYTK); Lifecore Biomedical, ... - Bluefield Daily Telegraph
Notice to Long-Term Shareholders of Cytokinetics, Inc. - GlobeNewswire
KeyBanc says momentum, strategic value building at Lifecore - MSN
Operating cash flow per share of Lifecore Biomedical, Inc. – DUS:LDE - TradingView — Track All Markets
How sustainable is Lifecore Biomedical Inc. stock dividend payout2026 world cup usa national team semifinals defensive leaders set piece tactics knockout prediction expert opinion - ulpravda.ru
2026-01-06 | Lifecore Biomedical, Inc. (LFCR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation | NDAQ:LFCR | Press Release - Stockhouse
Lifecore Biomedical (LFCR) Reports Q1 Loss, Beats Revenue Estimates - MSN
(LFCR) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Important Notice to Long-Term Shareholders of CarMax, Inc. - GlobeNewswire
PRN_FinancialWrapper - FinancialContent
2026-01-04 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Lifecore Biomedical, Inc. (LFCR) and Encourages Stockholders to Learn More About the Investigation | NDAQ:LFCR | Press Release - Stockhouse
Lifecore Biomedical (NASDAQ:LFCR) Upgraded at Zacks Research - Defense World
Can IDBI Bank Limited Rally Enough to Break EvenRelative Strength Index (RSI) & Big Gains Small Budget - earlytimes.in
Analysts Offer Insights on Healthcare Companies: Outlook Therapeutics (OTLK) and Lifecore Biomedical (LFCR) - The Globe and Mail
Lifecore Biomedical: The Turnaround Is Just Getting Started (NASDAQ:LFCR) - Seeking Alpha
Important Notice to Long-Term Shareholders of CarMax, Inc. (NYSE: KMX); Inspire Medical Systems, Inc. (NYSE: INSP); Integer Holdings Corp. (NYSE: ITGR); Lifecore Biomedical, Inc. (NASDAQ: LFCR): Grabar Law Office Investigates Claims on Your Behalf - GlobeNewswire
Analysts Conflicted on These Healthcare Names: Lifecore Biomedical (LFCR) and Xenon (XENE) - The Globe and Mail
Lifecore Biomedical Inc (LFCR) Stock Price, News & Analyst Forecast - eToro
KeyBanc maintains Sector Weight rating on Lifecore Biomedical stock By Investing.com - Investing.com UK
LFCR Deadline: LFCR Investors Have Opportunity to Lead Lifecore Biomedical, Inc. Securities Fraud Lawsuit - GuruFocus
(LFCR) Volatility Zones as Tactical Triggers - Stock Traders Daily
EBIT per share of Lifecore Biomedical, Inc. – DUS:LDE - TradingView — Track All Markets
HALPER SADEH LLC ENCOURAGES LIFECORE BIOMEDICAL, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS - PR Newswire
Lifecore Biomedical, Inc.(NasdaqGS: LFCR) added to NASDAQ Biotechnology Index - marketscreener.com
Lifecore Biomedical, Inc. (LFCR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Is Lifecore Biomedical Inc. stock overvalued by current metricsJuly 2025 Spike Watch & Technical Pattern Recognition Alerts - Улправда
Is Lifecore Biomedical Inc. stock positioned for long term growthJuly 2025 Sector Moves & Community Verified Watchlist Alerts - Улправда
One Lifecore Biomedical Insider Raised Their Stake In The Previous Year - Yahoo Finance
Can Lifecore Biomedical Inc. stock maintain operating marginsMarket Performance Recap & AI Enhanced Trade Execution Alerts - Улправда
Support Test: Is Lifecore Biomedical Inc. stock vulnerable to regulatory risksWeekly Trend Report & AI Based Buy/Sell Signal Reports - Улправда
Can Lifecore Biomedical Inc. (LDE) stock deliver strong annual returnsEarnings Overview Report & Daily Stock Trend Watchlist - ulpravda.ru
Can Lifecore Biomedical Inc. stock maintain growth trajectoryCEO Change & Real-Time Buy Signal Alerts - DonanımHaber
Can Lifecore Biomedical Inc. stock resist sector downturnsDollar Strength & Verified High Yield Trade Plans - DonanımHaber
Investment Report: Is Lifecore Biomedical Inc. stock overvalued by current metricsQuarterly Performance Summary & AI Powered Market Entry Strategies - Улправда
Lifecore Biomedical to Join Nasdaq Biotech Index - marketscreener.com
Lifecore Biomedical to be Added to Nasdaq Biotech Index - The Manila Times
Is Lifecore Biomedical Inc. stock vulnerable to regulatory risksJuly 2025 WrapUp & Consistent Return Investment Signals - Улправда
Lifecore signs CDMO agreement with global pharma company By Investing.com - Investing.com Nigeria
Entry Recap: Why Lifecore Biomedical Inc. stock is favored by top institutionsWeekly Trade Report & Weekly Momentum Picks - moha.gov.vn
Lifecore Biomedical, Inc. Signs CDMO Master Services Agreement with New Large Multinational Pharmaceutical Customer - marketscreener.com
0.37%
1.55%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):